Cargando…

HBV‐integrated local genomic alterations reveal multicentric independent occurrences of multifocal HCC

Detalles Bibliográficos
Autores principales:	Zou, Hao, Wang, Yinan, Lu, Lianfang, Yao, Ke, Wang, Chang, Ma, Kai, Zhu, Chengzhan, Guo, Zhongyi, Feng, Yujie, Wu, Zehua, Song, Mengqi, Zhou, Bin, Hu, Xiao, Han, Bing, Guo, Weidong, Qiu, Fabo, Zhang, Bingyuan, Qi, Xingsi, Wang, Xiaowei, Wang, Mengyao, Pan, Guangze, Sun, Qixuan, Cao, Jingyu, Gong, Song, Zhao, Zicheng, Sun, Chuandong, Lu, Shichun, Tian, Lantian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309081/ https://www.ncbi.nlm.nih.gov/pubmed/37382888 http://dx.doi.org/10.1002/ctm2.1313

Ejemplares similares

M3 muscarinic acetylcholine receptors regulate epithelial–mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway
por: Feng, Yujie, et al.
Publicado: (2018)

Effect of Microvascular Invasion on the Prognosis in Hepatocellular Carcinoma and Analysis of Related Risk Factors: A Two-Center Study
por: Yanhan, Wang, et al.
Publicado: (2021)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

New insights into a microvascular invasion prediction model in hepatocellular carcinoma: A retrospective study from the SEER database and China
por: Wang, Xingchang, et al.
Publicado: (2023)

Establishment and Application of a Novel Difficulty Scoring System for da Vinci Robotic Pancreatoduodenectomy
por: Sun, Hongfa, et al.
Publicado: (2022)

Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy
por: Ji, Mengling, et al.
Publicado: (2022)

Genomic Expression Profiling and Bioinformatics Analysis of Chronic Recurrent Multifocal Osteomyelitis
por: Huang, Kai, et al.
Publicado: (2021)

Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway
por: Zhou, Bin, et al.
Publicado: (2018)

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
por: Shi, Jihang, et al.
Publicado: (2023)

Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma
por: Ma, Kai, et al.
Publicado: (2022)

Anticancer Effects of Fufang Yiliu Yin Formula on Colorectal Cancer Through Modulation of the PI3K/Akt Pathway and BCL-2 Family Proteins
por: Dong, Bingzi, et al.
Publicado: (2020)

LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis
por: Zhao, Wei, et al.
Publicado: (2021)

HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
por: Chen, Lu, et al.
Publicado: (2018)

Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma
por: Feng, Yujie, et al.
Publicado: (2021)

The pathogenesis of multifocal osteonecrosis
por: Sun, Wei, et al.
Publicado: (2016)

A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Guangfeng, et al.
Publicado: (2021)

The role of (18)F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy
por: Wang, Guanyun, et al.
Publicado: (2023)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy
por: Wang, Guanyun, et al.
Publicado: (2023)

Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria
por: Zhang, Ningning, et al.
Publicado: (2020)

A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection
por: Wang, Jianhua, et al.
Publicado: (2022)

Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis
por: Song, Li, et al.
Publicado: (2022)

miR-346 Promotes HCC Progression by Suppressing Breast Cancer Metastasis Suppressor 1 Expression
por: Guo, Zhixian, et al.
Publicado: (2018)

Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2022)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC
por: Wang, Yixiu, et al.
Publicado: (2022)

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2023)

Geometric-phase intraocular lenses with multifocality
por: Lee, Seungmin, et al.
Publicado: (2022)

Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation
por: Li, Yinuo, et al.
Publicado: (2022)

Juglanthraquinone C Induces Intracellular ROS Increase and Apoptosis by Activating the Akt/Foxo Signal Pathway in HCC Cells
por: Hou, Ya-Qin, et al.
Publicado: (2016)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

A polymer acceptor with an optimal LUMO energy level for all-polymer solar cells
por: Ding, Zicheng, et al.
Publicado: (2016)

Bile acids promote the development of HCC by activating inflammasome
por: Chen, Wenbo, et al.
Publicado: (2023)

Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
por: Wang, Yao, et al.
Publicado: (2021)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
por: Luo, Wenyu, et al.
Publicado: (2022)

Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy
por: Wu, Zhiqiang, et al.
Publicado: (2020)

Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
por: Bai, Lu, et al.
Publicado: (2022)

Pretreatment Metabolic Parameters Measured by (18)F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C
por: Wang, Guanyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5utv71vqo9n4v8mq4v1p67ak72